Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing 18F-FDG PET/CT

被引:14
作者
Caobelli, Federico [1 ]
Pizzocaro, Claudio [1 ]
Paghera, Barbara [2 ]
Guerra, Ugo P. [1 ]
机构
[1] Fdn Poliambulanza, Dept Nucl Med, I-25100 Brescia, Italy
[2] Brescia Civ Hosp, Dept Nucl Med, Brescia, Italy
关键词
diabetes; F-18-FDG PET/CT; hyperglycemia; short-acting insulin; GLUCOSE LEVELS; FDG UPTAKE; CANCER; TRANSPORT; TUMOR;
D O I
10.1097/MNM.0b013e32835d1034
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The objective of this study was to evaluate the usefulness and impact of insulin administration before an F-18-FDG PET/computed tomography (CT) examination in diabetic patients in order to propose an optimized protocol that can reduce blood glucose levels without increasing muscular F-18-FDG uptake. A total of 130 patients underwent an F-18-FDG PET/CT. Twenty patients had glucose levels greater than 180 mg/dl and received endovenous insulin before F-18-FDG injection (group 1); 10 patients had glucose levels greater than 160 mg/dl and lower than 200 mg/dl and received no insulin (group 2); 100 patients were euglycemic (group 3). Biodistribution was adequate in 19 of 20 patients in group 1. Values of standardized uptake value in the gluteal muscle were 0.50 +/- 0.18 for group 1, 0.48 +/- 0.10 for group 2, and 0.49 +/- 0.08 for group 3; no significant differences in muscular F-18-FDG uptake could be found among the three groups. No adverse events were recorded. In conclusion, our protocol has been demonstrated to be safe and effective, with only a minor impact on glucose biodistribution and apparently without affecting PET accuracy. Nucl Med Commun 34: 271-275 (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 15 条
[1]   Glucose transporters in cancer metabolism [J].
Adekola, Kehinde ;
Rosen, Steven T. ;
Shanmugam, Mala .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) :650-654
[2]   Interactions between delivery, transport, and phosphorylation of glucose in governing uptake into human skeletal muscle [J].
Bertoldo, Alessandra ;
Pencek, R. Richard ;
Azuma, Koichiro ;
Price, Julie C. ;
Kelley, Carol ;
Cobelli, Claudio ;
Kelley, David E. .
DIABETES, 2006, 55 (11) :3028-3037
[3]   FDG-PET: procedure guidelines for tumour imaging [J].
Bombardieri, E ;
Aktolun, C ;
Baum, RP ;
Bishof-Delaloye, A ;
Buscombe, J ;
Chatal, JF ;
Maffioli, L ;
Moncayo, R ;
Mortelmans, L ;
Reske, SN .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (12) :BP115-BP124
[4]   Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes [J].
Cline, GW ;
Petersen, KF ;
Krssak, M ;
Shen, J ;
Hundal, RS ;
Trajanoski, Z ;
Inzucchi, S ;
Dresner, A ;
Rothman, DL ;
Shulman, GI .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :240-246
[5]   The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: A pet study in liver metastases from colorectal carcinomas [J].
Crippa, F ;
Gavazzi, C ;
Bozzetti, F ;
Chiesa, C ;
Pascali, C ;
Bogni, A ;
DeSanctis, V ;
Decise, D ;
Schiavini, M ;
Cucchetti, G ;
Bombardieri, E .
TUMORI, 1997, 83 (04) :748-752
[6]  
Diederichs CG, 1998, J NUCL MED, V39, P1030
[7]   Functional limitations to glucose uptake in muscles comprised of different fiber types [J].
Halseth, AE ;
Bracy, DP ;
Wasserman, DH .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (06) :E994-E999
[8]  
LANGEN KJ, 1993, J NUCL MED, V34, P355
[9]  
LINDHOLM P, 1993, J NUCL MED, V34, P1
[10]  
MINN H, 1994, CANCER, V73, P1490, DOI 10.1002/1097-0142(19940301)73:5<1490::AID-CNCR2820730528>3.0.CO